Hypertension, Systolic
8
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Sympathetic Regulation of Large Artery Stiffness in Humans With ISH
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Treatment of Hypertension During Sleep
Olive Polyphenols in Cardiovascular Prevention
A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients
Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People